ATROVENT NASAL 0.03 %, nasal solution in a spray bottle bottle, 15 ml
Active ingredients: Ipratropium bromide, Anhydrous ipratropium bromide
Commercialized according to BDPMDispensing in France: Prescription only
Solution for sprayingbottle, 15 mlnasale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ATROVENT NASAL 0,03 POUR CENT, solution nasale en flacon pulvérisateur
- Pharmaceutical form
- solution pour pulvérisation
- Route of administration
- nasale
- Presentation description
- 1 flacon(s) pulvérisateur(s) en verre brun de 15 ml avec valve doseuse
- Marketing authorisation holder
- EG LABO - LABORATOIRES EUROGENERICS
- Reimbursement according to BDPM
- 15%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Oct 1996
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65756091CIP73392756CIP133400933927561Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BROMURE D'IPRATROPIUMsolution | 0,03131 g · 100 ml | SA |
| BROMURE D'IPRATROPIUM ANHYDREsolution | 0,03000 g · 100 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.